Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT - New York Stock Exchange, Inc. - US2244411052 - Common Stock - Currency: USD

58.61  -0.69 (-1.16%)

After market: 58.61 0 (0%)

Fundamental Rating

5

Overall CXT gets a fundamental rating of 5 out of 10. We evaluated CXT against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT belongs to the best of the industry regarding profitability, there are concerns on its financial health. CXT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CXT had positive earnings in the past year.
CXT had a positive operating cash flow in the past year.
In the past 5 years CXT has always been profitable.
CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.92%, CXT belongs to the top of the industry, outperforming 83.20% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.18%, CXT belongs to the top of the industry, outperforming 84.80% of the companies in the same industry.
CXT has a better Return On Invested Capital (10.73%) than 85.60% of its industry peers.
CXT had an Average Return On Invested Capital over the past 3 years of 13.27%. This is above the industry average of 9.16%.
Industry RankSector Rank
ROA 6.92%
ROE 15.18%
ROIC 10.73%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CXT's Profit Margin of 11.17% is amongst the best of the industry. CXT outperforms 87.20% of its industry peers.
CXT's Profit Margin has declined in the last couple of years.
The Operating Margin of CXT (19.02%) is better than 96.00% of its industry peers.
In the last couple of years the Operating Margin of CXT has remained more or less at the same level.
CXT has a better Gross Margin (43.43%) than 75.20% of its industry peers.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 19.02%
PM (TTM) 11.17%
GM 43.43%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CXT has more shares outstanding
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.77 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CXT (2.77) is worse than 64.00% of its industry peers.
CXT has a debt to FCF ratio of 5.77. This is a neutral value as CXT would need 5.77 years to pay back of all of its debts.
The Debt to FCF ratio of CXT (5.77) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.73 indicates that CXT is somewhat dependend on debt financing.
CXT has a Debt to Equity ratio of 0.73. This is amonst the worse of the industry: CXT underperforms 85.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.77
Altman-Z 2.77
ROIC/WACC1.15
WACC9.32%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.20 indicates that CXT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.20, CXT is not doing good in the industry: 88.80% of the companies in the same industry are doing better.
A Quick Ratio of 0.92 indicates that CXT may have some problems paying its short term obligations.
With a Quick ratio value of 0.92, CXT is not doing good in the industry: 84.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.92
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -2.22% in the last year.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
The Revenue has grown by 9.28% in the past year. This is quite good.
Measured over the past years, CXT shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
EPS 1Y (TTM)-2.22%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-36.47%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

Based on estimates for the next years, CXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.70% on average per year.
Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 7.76% on average per year.
EPS Next Y-2.86%
EPS Next 2Y6.72%
EPS Next 3Y8.7%
EPS Next 5YN/A
Revenue Next Year6.56%
Revenue Next 2Y7.54%
Revenue Next 3Y7.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.80 indicates a correct valuation of CXT.
CXT's Price/Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 89.60% of the companies in the same industry.
When comparing the Price/Earnings ratio of CXT to the average of the S&P500 Index (27.30), we can say CXT is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.05, the valuation of CXT can be described as correct.
Based on the Price/Forward Earnings ratio, CXT is valued cheaper than 92.80% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CXT is valued a bit cheaper.
Industry RankSector Rank
PE 14.8
Fwd PE 12.05
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaper than 87.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXT is valued a bit cheaper than the industry average as 72.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.1
EV/EBITDA 10.03
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CXT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.72%
EPS Next 3Y8.7%

6

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.76, CXT pays a better dividend. On top of this CXT pays more dividend than 88.00% of the companies listed in the same industry.
With a Dividend Yield of 1.20, CXT pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

22.14% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.14%
EPS Next 2Y6.72%
EPS Next 3Y8.7%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (7/11/2025, 8:04:00 PM)

After market: 58.61 0 (0%)

58.61

-0.69 (-1.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners104.34%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change5.38%
Market Cap3.36B
Analysts81.82
Price Target87.87 (49.92%)
Short Float %10.71%
Short Ratio12.27
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP22.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-30 2025-05-30 (0.17)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.45%
Min EPS beat(2)-1.06%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)1%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)9
Avg EPS beat(12)6.83%
EPS beat(16)13
Avg EPS beat(16)10.31%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)2.69%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.94%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.75%
PT rev (3m)-1.36%
EPS NQ rev (1m)4.82%
EPS NQ rev (3m)-7.47%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)-0.48%
Revenue NQ rev (1m)7.11%
Revenue NQ rev (3m)6.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.83%
Valuation
Industry RankSector Rank
PE 14.8
Fwd PE 12.05
P/S 2.24
P/FCF 24.1
P/OCF 18.13
P/B 3.04
P/tB N/A
EV/EBITDA 10.03
EPS(TTM)3.96
EY6.76%
EPS(NY)4.86
Fwd EY8.3%
FCF(TTM)2.43
FCFY4.15%
OCF(TTM)3.23
OCFY5.52%
SpS26.21
BVpS19.29
TBVpS-4.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.92%
ROE 15.18%
ROCE 15.33%
ROIC 10.73%
ROICexc 11.69%
ROICexgc 39.53%
OM 19.02%
PM (TTM) 11.17%
GM 43.43%
FCFM 9.28%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexcg growth 3Y39.7%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.77
Debt/EBITDA 2.14
Cap/Depr 51.17%
Cap/Sales 3.06%
Interest Coverage 6.27
Cash Conversion 49.36%
Profit Quality 83.04%
Current Ratio 1.2
Quick Ratio 0.92
Altman-Z 2.77
F-Score4
WACC9.32%
ROIC/WACC1.15
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.22%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-36.47%
EPS Next Y-2.86%
EPS Next 2Y6.72%
EPS Next 3Y8.7%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next Year6.56%
Revenue Next 2Y7.54%
Revenue Next 3Y7.76%
Revenue Next 5YN/A
EBIT growth 1Y2.29%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.32%
EBIT Next 3Y14.68%
EBIT Next 5YN/A
FCF growth 1Y-31.2%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-22.51%
OCF growth 3Y-8.23%
OCF growth 5YN/A